Dr. Maxian studies how different factors affect the development and function of placental cells during pregnancy. She investigates conditions like preeclampsia, a serious pregnancy complication that can harm both mothers and babies, by looking for early warning signs in blood and placental tissue. Additionally, she explores how hormones affect the placenta and fetal growth, especially in women with conditions like polycystic ovary syndrome (PCOS). Her research involves understanding the roles of specific proteins and signaling pathways that are crucial for healthy placental development and function.
Key findings
In a study on early onset preeclampsia, specific markers were found to increase as early as the first trimester, which can help in better diagnosis and treatment.
Research on the protein TAZ revealed that its deficiency disrupts the development of extravillous trophoblasts, leading to significant cell death that could affect pregnancy outcomes.
A method developed for isolating first trimester placental cells achieved a purity of 90-99%, which is crucial for studying placental interactions and health.
Frequently asked questions
Does Dr. Maxian study preeclampsia?
Yes, she researches early indicators and mechanisms associated with preeclampsia to improve diagnosis and treatment outcomes.
What is the role of hormones in Dr. Maxian's research?
She investigates how high levels of male hormones during pregnancy affect placental development and potential risks to the fetus.
How does Dr. Maxian's work impact patients?
Her research aims to provide insights that can enhance pregnancy care and reduce complications for pregnant women and their babies.
Publications in plain English
Step-by-step protocol for isolating the entire repertoire of human first trimester placental cells.
2025
Placenta
Maxian T, Prandstetter AM, Waldhäusl H, Höbler AL, Meinhardt G +4 more
Plain English This study focused on developing a thorough method to isolate specific types of cells from the human placenta during the first trimester of pregnancy. The researchers found that different steps of their process led to various cell types, achieving very high purity (90-99%) of important cells called trophoblasts in some phases and successfully isolating fetal cells in the later steps. This research is important because it provides a reliable way to study how these placental cells interact, which is crucial for understanding healthy pregnancy and fetal development.
Who this helps: This research benefits researchers studying pregnancy and placental health.
Senescent Syncytiotrophoblast Secretion During Early Onset Preeclampsia.
2025
Hypertension (Dallas, Tex. : 1979)
Nonn O, Debnath O, Valdes DS, Sallinger K, Secener AK +37 more
Plain English This study looked at early onset preeclampsia, a serious condition in pregnancy that can harm both mothers and babies. Researchers found that certain markers in the placenta and maternal blood, specifically PAI-1 and activin A, were increased as early as the first trimester, long before preeclampsia was diagnosed. Recognizing these markers early could lead to better diagnosis and treatment, improving outcomes for pregnant women and their babies.
Who this helps: This helps pregnant women at risk for preeclampsia and their healthcare providers.
The multifaceted roles of the transcriptional coactivator TAZ in extravillous trophoblast development of the human placenta.
2025
Proceedings of the National Academy of Sciences of the United States of America
Meinhardt G, Waldhäusl H, Lackner AI, Wächter J, Maxian T +11 more
Plain English This study focused on understanding the role of a protein called TAZ in the development of specific cells in the human placenta known as extravillous trophoblasts (EVTs). The researchers found that TAZ is critical for the proper growth and function of EVTs, impacting their movement and survival; when TAZ was reduced or blocked, EVT development was disrupted, leading to cell death in various tests. This is important because problems in EVT function are linked to serious pregnancy issues like preeclampsia and restricted fetal growth.
Who this helps: This helps patients facing pregnancy complications and doctors treating them.
Plain English Researchers studied how low oxygen levels affect early human placental cells called trophoblast stem cells. They found that low oxygen helps these cells multiply but stops them from turning into more specialized cells needed for the placenta, mainly because of decreased levels of a protein called GCM1. Without GCM1, the cells also lose their ability to stop growing once they've formed enough tissue, which is important for proper placenta development.
Who this helps: This research benefits doctors and scientists studying pregnancy and placental health.
Plain English The study looked at how high levels of male hormones during pregnancy, common in women with polycystic ovary syndrome (PCOS), affect the development of the placenta and fetus. Researchers found that mice exposed to these hormones had problems with placenta growth and development, leading to the death of embryos at mid-pregnancy. By using a medication to block the effects of these hormones, they were able to prevent some of these developmental issues, which suggests potential ways to treat related complications in pregnancies affected by PCOS.
Who this helps: This helps patients with PCOS and their unborn children by identifying possible treatment options to reduce pregnancy complications.
Plain English This study looked at how low oxygen levels affect the development of human trophoblast stem cells, which are important for forming the placenta. Researchers found that while these cells thrive in low oxygen, this environment prevents them from differentiating into necessary cells for proper placental function. Specifically, they discovered that a key protein called GCM1, which promotes cell differentiation, is lower under low oxygen, leading to a failure in developing essential placental cells.
Who this helps: This research benefits patients, especially pregnant women, by providing insights into conditions that could lead to placental disorders.
Spatial multiomic landscape of the human placenta at molecular resolution.
2024
Nature medicine
Ounadjela JR, Zhang K, Kobayashi-Kirschvink KJ, Jin K, J C Russell A +19 more
Plain English This study looked closely at the structure and function of the placenta during the first trimester of pregnancy. Researchers used advanced techniques to analyze the genes and regulatory networks that help the placenta adapt and thrive in the challenging environment of the uterus. They found complex gene expression patterns that may affect how the placenta develops and how it can lead to complications during pregnancy, revealing important details about the placental cells' interactions and functions.
Who this helps: This helps doctors and researchers working on pregnancy-related issues and complications.
Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta.
2022
Proceedings of the National Academy of Sciences of the United States of America
Haider S, Lackner AI, Dietrich B, Kunihs V, Haslinger P +7 more
Plain English This study looked at how certain signals in the body influence the development of a specific type of cell in the placenta called extravillous trophoblasts (EVTs). Researchers found that a signaling pathway known as TGF-β is essential for these cells to develop properly. Specifically, when they activated this pathway, the EVTs produced important proteins that are characteristic of healthy placental functioning, which is crucial for a successful pregnancy.
Who this helps: This benefits expectant mothers and their healthcare providers by improving understanding of placental development and associated complications.
Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
2021
International journal of molecular sciences
Maxian T, Gerlitz L, Riedl S, Rinner B, Zweytick D
Plain English This study looked at two peptides, RDP215 and a modified version called 9D-RDP215, which target a specific part of cancer cells linked to melanoma and glioblastoma. The researchers found that the modified peptide 9D-RDP215 was more effective at damaging cancer cells and was more stable in the presence of blood serum, leading to substantial cell death in tumor models. This research matters because it suggests that using D-amino acids in cancer treatment can enhance the effectiveness and stability of antitumor peptides.
Who this helps: This benefits cancer patients, particularly those with melanoma and glioblastoma.
Skin breakdown following circumferential pelvic antishock sheeting: a case report.
2005
Journal of orthopaedic trauma
Schaller TM, Sims S, Maxian T
Plain English This study looked at a method called circumferential pelvic antishock sheeting, which uses a standard bed sheet to stabilize the pelvis after serious injuries. The researchers found that while this method is helpful in reducing bleeding and pain, it can sometimes cause skin damage, making it difficult to perform necessary surgery on pelvic fractures. Specifically, they reported a case where skin breakdown prevented surgery from being completed.
Who this helps: This helps doctors treating patients with severe pelvic injuries.
Sandra Haider Martin Knöfler Anna-Maria Prandstetter Andreas I Lackner Gudrun Meinhardt Jürgen Pollheimer Johain R Ounadjela Ke Zhang Koseki J Kobayashi-Kirschvink Kang Jin
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.